Cancer Metabolomics

Based on gene expression and DNA grouping, cancer genomics controls how the contrast between tumour cells and regular cells is portrayed. The goal of this inquiry is to better understand the fundamental hereditary characteristics of tumour progression, the alteration of the disease's genome, and the role of treatment in the cancer microenvironment. The study of the chemical traces a metabolite leaves behind during digestion is known as metabolomics. Examining the metabolite profile for sedative improvement in the event of the presence of tumour cells will be of the utmost importance. One of the many discoveries in disease metabolomics is the noninvasive validation of metabolic biomarkers from the bodily fluid of tumour patients.

    Related Conference of Cancer Metabolomics

    December 04-05, 2023

    3rd World Summit on Transcriptomics

    Venice, Italy
    December 04-05, 2023

    17th Global meet on Rheology & Rheometry

    Taipei, Taiwan
    December 04-05, 2023

    46th International Summit on Human Anatomy & Physiology

    Taipei, Taiwan
    December 05-06, 2023

    2nd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 07-08, 2023

    6th Annual Congress on Emergency Medicine and Acute Care

    Prague, Czech Republic
    December 18-19, 2023

    3rd World Congress on Pain Medicine and Management

    London, UK
    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands

    Cancer Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in